Monthly anemia shot works as well as weekly in dialysis patients
NCT ID NCT00560404
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 21 times
Summary
This study tested whether a once-monthly injection of Mircera could keep hemoglobin levels stable in dialysis patients with anemia, compared to the standard epoetin alfa given more often. About 233 adults on dialysis took part. The goal was to see if the monthly shot was as safe and effective at maintaining healthy red blood cell levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Belo Horizonte, 30150-320, Brazil
-
Study site
Brasília, 70390-108, Brazil
-
Study site
Campinas, 13086-970, Brazil
-
Study site
Campo Grande, 79002-073, Brazil
-
Study site
Cariacica, 29152-230, Brazil
-
Study site
Curitiba, 80050-350, Brazil
-
Study site
Curitiba, 80440-020, Brazil
-
Study site
Fortaleza, 60430160, Brazil
-
Study site
Jaboatão dos Guararapes, 54400-170, Brazil
-
Study site
Joinville, 89227-680, Brazil
-
Study site
Juiz de Fora, 36036900, Brazil
-
Study site
Londrina, 86015-000, Brazil
-
Study site
Natal, 59020-110, Brazil
-
Study site
Porto Alegre, 90035-903, Brazil
-
Study site
Porto Alegre, 90610000, Brazil
-
Study site
Ribeirão Preto, 14025-170, Brazil
-
Study site
Rio de Janeiro, Brazil
-
Study site
Salvador, 40110-060, Brazil
-
Study site
São José do Rio Preto, 15090-000, Brazil
-
Study site
São Luís, 65020-305, Brazil
-
Study site
São Paulo, 01246-903, Brazil
-
Study site
São Paulo, 01323-900, Brazil
-
Study site
São Paulo, 01532-001, Brazil
-
Study site
São Paulo, 03065-000, Brazil
-
Study site
São Paulo, O4023, Brazil
-
Study site
Sorocaba, 18030-210, Brazil
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.